B

Benitec Biopharma

D
BNTC
USD
0.545
(5.2228%)
Market Closed
1,207.00
Volume
-0.58334
EPS
-
Div Yield
-1.992740
P/E
110,745,586.62
Market Cap
Today
5.2228%
1 Week
4.571%
1 Month
13.430%
6 Months
33.252%
12 Months
197.561%
Year To Date
233.739%
All Time
0%

Title:
Benitec Biopharma

Sector:
Healthcare
Industry:
Biotechnology
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.
Do you need help or have a question?